Unveiling the nexus: Understanding post-COVID parkinsonism and its neurological ramifications

Kow CS 1 , Ramachandram DS 2 , Hasan SS 3 , Thiruchelvam K 4

Affiliations 

  • 1 School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia
  • 2 School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia
  • 3 School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom
  • 4 School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia. Electronic address: kaeshaelya@imu.edu.my
Parkinsonism Relat Disord, 2024 Jul;124:106974.
PMID: 38670906 DOI: 10.1016/j.parkreldis.2024.106974

Abstract

This article explores the potential link between COVID-19 and parkinsonism, synthesizing existing evidence and recent research findings. It highlights limitations in current understanding, emphasizes the direct impact of the virus on dopamine neurons, and calls for continued research to elucidate long-term neurological implications and optimize patient care strategies.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications